Premium Research
By Sean Brodrick On December 6, 202212:05 PM Eastern
Most traders are starting to price in another leg down.
By Mike Larson On December 6, 202208:00 AM Eastern
A healthy dose of drug stocks has turned out to be a great investment prescription.
Strategic Options
Subscription
By Jon D. Markman On December 6, 202206:30 AM Eastern
In 2022, investors have contended with a messy war in Eastern Europe, worldwide inflation and supply chain bottlenecks. It’s been a tough slog, yet there are better times ahead.
The world is...
By Jon D. Markman On December 5, 202203:08 PM Eastern
Stocks are kicking off the week with losses and bond yields climbed as a U.S. services gauge rose unexpectedly.
By Kenny Polcari On December 5, 202212:00 PM Eastern
Today, I’m talking to Nilus Mattive, associate editor of Safe Money Report.
By Nilus Mattive On December 5, 202212:00 PM Eastern
This week, I have the pleasure of sitting down with Kenny Polcari, host of Wealth & Wisdom, who interviews those in the know.
Strategic Options
Subscription
By Jon D. Markman On December 5, 202206:30 AM Eastern
Bears started Friday with all guns blazing. The S&P 500 splattered to an early 1.2% loss on a crazy hot November payrolls report.
That's when bulls sneaked into the battlefield and nearly...
Disruptors & Dominators
Subscription
By Tony Sagami On December 2, 202204:00 PM Eastern
While the stock market has many investors worried, here’s why the next major move will be upward.
When Fed Chair Powell confirmed smaller hikes on Wednesday, your new covered call started to trigger.
Wealth Megatrends
Subscription
By Sean Brodrick On December 2, 202209:44 AM Eastern
A slew of issues tossed the market around this week, but your portfolio’s still doing great.